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ABSTRACT
A questionnaire on the treatment of asthma was sent to 586 
physicians. They consisted of specialists authorized by the 
Japanese Society of Allergology and councillors of the society 
who were treating patients with bronchial asthma. Of the total 
of 306 (52%) respondents, 241 replied to questions relating to 
adult asthma and 129 to questions relating to childhood 
asthma (including duplicate replies). For acute treatment, meth-
ods most commonly selected by physicians were, in increasing 
order of popularity, for adults: parenteral aminophylline, oxy-
gen inhalation, parenteral steroids and parenteral adrenaline; 
for schoolchildren (6-16 years): parenteral aminophylline,
inhaled β-stimulant, oxygen inholation, inhaled β-stimulont+
disodium cromoglycate (DSCG), porenterol steroids; ond for
infonts (≦5yeors): inhaled β-stimulant, porenteral amino-
phylline, oxygen inhalation, inholed β-stimulant DSCG ond
parenteral steroids. For maintenance treatment, methods most 
commonly selected by physicians were, in increasing order of 
popularity, for adults: oral administration of sustained-release 
theophylline, inhaled steroids and DSCG inhalation; for school-
children (6-16 years): DSCG inhalation, oral administration of 
sustained-release theophylline, oral administration of anti-
allergic ogent preparation and β-stimulant+DSCG inhalant;
and for infants: DSCG inhalation, oral administration of sus-
tained-release theophylline, oral administration of antiallergic
agent preparation and β-stimulant+DSCG inhalant. The
questionnaire results clearly showed that different drugs were 
selected for the treatment of asthma in adults, schoolchildren 
and infants.
Key words: asthma management, bronchial asthma, ques-
tionnaire survey, Japan
INTRODUCTION
The Bronchial Asthma Group of the Comprehensive Research 
Project on Allergy of the Ministry of Health and Welfare con-
ducted a questionnaire survey in November 1993 to examine 
the current status of asthma treatment in Japan. The results of 
this survey pertaining to diagnosis, patient education and man-
agement of asthma have already been reported.1 In the present 
paper, survey results concerning treatment methods used by 
physicians treating asthmatics are reported.
METHODS
As described in the survey report on diagnosis, patient educa-
tion and management of asthma, a questionnaire was sent to 
586 physicians, including specialists authorized by the Japanese 
Society of Allergology and consultants of the society, who were 
treating patients with asthma.1 Of the total of 306 (52%) 
respondents, 177 were internists, 65 were pediatricians and 64 
were physicians who saw patients in both medical and pediatric 
departments. A total of 241 replied to the questions relating 
to adult asthma and 129 to those relating to childhood asthma. 
In the questionnaire, all patients with bronchial asthma were
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classified into three age groups: adults (>16years), school-
age children (6-16years) and infants (≦5years).
 All questions are shown in Tables 1-2. The following instruc-
tions were given in the preamble of the questionnaire. 
  Your answers to questions should reflect your actual manage-
ment of individual patients. Please answer questions using the fol-
lowing scores for approximate frequencies, from 0 to 3: (Almost) 
Never (<10%)=0, Sometimes (10-50%)=1, Often (50-90%)=2 
and (Nearly) Always (>90%)=3.
RESULTS
Acute treatment
Replies to question 1 in Table 1 are shown in Figs 1-3. For adult 
asthma, parenteral aminophylline (including i. v. drip-infusion), 
oxygen inhalation and parenteral steroids (including i. v. drip-
infusion) were given first priority, followed by parenteral adrena-
line and inhaled β-stimulant (Fig.1). On the other hand, for
school-age children (6-16 years), parenteral aminophylline,
inhaled β-stimulant and oxygen inhalation were given first prior-
ity, followed by parenteral steroids. Inhalation of β-stimulant+
DSCG was often used instead of inhaled β-stimulant alone (Fig.
Table 1. Acute treatment
Table 2. Maintenance treatment
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Table 2. continued 2). For infants (≦5 years), inhaled β-stimulant, parenteral amino-
phylline and oxygen inhalation were given first priority, followed
by inhaled β-stimulant+DSCG and parenteral steroids (Fig. 3).
  Other results are shown in Table 1.
Maintenance treatment
Replies to question 1 in Table 2 are shown in Figs 4-6. In the 
treatment of adult asthma, high priority was given to the oral 
administration of sustained-release theophylline, inhaled
steroids and inhaled  β-stimulants, followed by DSCG inhala-
tion, oral administration of β-stimulants and oral administration
of antiallergic agents (Fig. 4). In the treatment of school-age 
children, highest priority was given to DSCG inhalation, fol-
lowed by oral administration of sustained-release of theo-
phylline and antiallergic agents. Inhaled β-stimulant+DSCG
was also commonly used (Fig. 5). On the other hand, for
infants, oral administration of antiallergic agents, DSCG
inhalation and oral administration of long-acting theophylline
were given highest priority, followed by inhaled β-stimulant+
DSCG and oral administration of β-stimulant. (Fig. 6).
 Replies to questions 4 and 5 in Table 2 are shown in Figs 7 
and 8, respectively.
  Normal dosage of inhaled steroids was 8.0±3.9 puffs/day
(maximum dosage: 21.5±10.4 puffs/day) for adults, 5.5±2.3
puffs/day (max.12.6±6.2) for schoolchildren (6-16years), and
4.1±1.9puffs,/day (max.8.7±4.4 for infants(≦5 years). One
puff contained 50μg of beclomethasone dipropionate (BDP).
  Other replies are shown in Table 2.
Fig. 1 Popularity of various methods for treating severe acute episodes of asthma in adult patients
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Fig. 2 Popularity of various methods for treating severe acute episodes of asthma in schoolchildren patients (6-16 years).
Fig. 3 Popularity of various methods fortreating severe acute episodes of asthma in infant patients (≦5 years).
DISCUSSION
Conducting surveys to determine the current status of asthma 
treatment is important in improving treatment and management 
of asthma patients and reducing asthma mortality. 
 A survey on asthma treatment, together with a survey of opinions
about the present Guidelines on Diagnosis and Treatment of 
Asthma was conducted. As previously reported, the results showed 
that the guidelines were very much appreciated by the physicians 
who responded to this survey.2 The present survey was conducted 
6 months after the guidelines were issued in 1993; therefore, 
replies may have been affected by their recommendations.
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Fig. 4 Popularity of various methods of maintenance therapy for adult patients with asthma.
Fig. 5 Popularity of various methods of maintenance therapy for schoolchildren patients (6-16 years) with asthma.
 Since 1989, asthma treatment guidelines have been issued 
by countries other than Japan,4-8 including the Global Initiative 
for Asthma which was recently issued by National Institutes of 
Health (NIH) and National Heart, Lung and Blood Institute 
(NHLBI).9
 The present survey revealed that different drugs are being 
used to treat asthma in adults, schoolchildren and infants. 
Comparison of Japanese asthma treatment methods with those 
described in the guidelines of other countries showed that 
the administration of theophylline, oral B-stimulant and oral
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Fig. 6 Popularity of various methods of maintenance therapy for infant patients (≦5years) with asthma.
Fig. 7 Usual and maximum recommended metered doses of inhaled
β-stimulant, reported as number of puffs/day.
Fig. 8 Usual and maximum recommended metered doses of inhaled 
steroid (beclomethasone dipropionate [BDP) reported as number of 
puffs/day.
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antiallergic agents is more extensive in Japan than in other 
countries, irrespective of patient age. 
 At present, the anti-allergic agents most widely prescribed in 
Japan are synthetic anti-enzyme drugs, which suppress the liber-
ation of chemical mediators in type I allergic reactions. All 13 
antiallergic agents, which were commercially available at the 
time of the survey, were included in this category. If drugs being 
currently developed are taken into consideration, then in future, 
the definition of the antiallergic agent will have to be broadened 
and antiallergic agents will have to be classified into the follow-
ing categories: (i) drugs suppressing the liberation of chemical 
mediators (i. e. synthetic anti-enzyme drugs); (ii) antagonists of 
chemical mediators; and (iii) immunosuppressants.3
 The most interesting result of this survey was the heavy use of 
inhaled B-stimulants, in many cases at the maximum daily 
allowable frequency or higher, for the treatment of adult asthma
(Fig. 7). In Japan, no long-acting inhaled β-stimulants are
commercially available to date; only short-acting or medium-
long-acting preparations are available. However, care must be 
taken to avoid excessive use of these inhalants; that is more than
21 puffs a day, because repeated use of inhaled β-stimulants
has been shown to increase the number of deaths from 
asthma.10 
 Results of future surveys on the treatment of asthma may be 
affected not only by the Japanese guidelines, but also by the 
recommendations of the Global Initiative for Asthma. 
Thereafter, all results will be thoroughly discussed in order to 
establish more appropriate means for managing asthmatics. 
We are confident that the results of the present survey will be 
instrumental in improving the Guidelines on Diagnosis and 
Treatment of Asthma in Japan.
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